US Cannabis Council Statement on Appointment of First FDA Cannabis Research and Regulation Advisor

September 27, 2022

Contact: Sarah Davey Wolman, 202-834-3725, press@uscannabiscouncil.org 

WASHINGTON, D.C. – For the first time, the U.S. Food and Drug Administration (FDA) has appointed an advisor on cannabis research and regulation. Norman Birenbaum will serve as senior public health advisor at the FDA’s Center for Regulatory Programs.

US Cannabis Council (USCC) CEO, Khadijah Tribble, released the following statement:

“We’re pleased that the Biden administration has signaled its growing interest in good-faith engagement on cannabis issues by creating a new adviser position within the FDA dedicated to cannabis research and regulation. Mr. Birenbaum’s vast experience managing multiple states’ medical cannabis efforts will surely inform how he approaches the challenges and opportunities ahead for our growing industry. The USCC is ready and eager to work with Mr. Birenbaum on all aspects of cannabis reform.”

# # #

The US Cannabis Council (USCC) is the voice of America's regulated cannabis industry. Our business members include many of the largest cannabis companies in the nation, and our nonprofit members are leaders in cannabis policy, criminal justice reform, and more. By harnessing the collective power and reach of our 60+ member companies and nonprofits, we have become a leading force for ending federal prohibition and creating an equitable and values-driven cannabis industry. For more information visit https://www.uscc.org/